INBS vs. VVOS, OSA, AVGR, NURO, PSTV, VAPO, BTCY, TMDIF, VERO, and TNON
Should you be buying Intelligent Bio Solutions stock or one of its competitors? The main competitors of Intelligent Bio Solutions include Vivos Therapeutics (VVOS), ProSomnus (OSA), Avinger (AVGR), NeuroMetrix (NURO), Plus Therapeutics (PSTV), Vapotherm (VAPO), Biotricity (BTCY), Titan Medical (TMDIF), Venus Concept (VERO), and Tenon Medical (TNON). These companies are all part of the "surgical & medical instruments" industry.
Vivos Therapeutics (NASDAQ:VVOS) and Intelligent Bio Solutions (NASDAQ:INBS) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, community ranking, analyst recommendations, institutional ownership, media sentiment, risk and valuation.
26.4% of Vivos Therapeutics shares are owned by institutional investors. Comparatively, 33.0% of Intelligent Bio Solutions shares are owned by institutional investors. 9.6% of Vivos Therapeutics shares are owned by insiders. Comparatively, 0.3% of Intelligent Bio Solutions shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Vivos Therapeutics has a net margin of -117.06% compared to Vivos Therapeutics' net margin of -354.86%. Vivos Therapeutics' return on equity of -210.36% beat Intelligent Bio Solutions' return on equity.
Vivos Therapeutics has a beta of 8.03, indicating that its share price is 703% more volatile than the S&P 500. Comparatively, Intelligent Bio Solutions has a beta of 4.87, indicating that its share price is 387% more volatile than the S&P 500.
Vivos Therapeutics received 12 more outperform votes than Intelligent Bio Solutions when rated by MarketBeat users.
Intelligent Bio Solutions has lower revenue, but higher earnings than Vivos Therapeutics. Vivos Therapeutics is trading at a lower price-to-earnings ratio than Intelligent Bio Solutions, indicating that it is currently the more affordable of the two stocks.
In the previous week, Vivos Therapeutics had 6 more articles in the media than Intelligent Bio Solutions. MarketBeat recorded 8 mentions for Vivos Therapeutics and 2 mentions for Intelligent Bio Solutions. Vivos Therapeutics' average media sentiment score of 0.44 beat Intelligent Bio Solutions' score of 0.31 indicating that Intelligent Bio Solutions is being referred to more favorably in the news media.
Summary
Vivos Therapeutics and Intelligent Bio Solutions tied by winning 7 of the 14 factors compared between the two stocks.
Get Intelligent Bio Solutions News Delivered to You Automatically
Sign up to receive the latest news and ratings for INBS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding INBS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Intelligent Bio Solutions Competitors List
Related Companies and Tools
